Article · 19 Jun 2026
Conference abstract
Development and Optimization of Venlafaxine HCl matrix-type transdermal patch by three-factor, three-level factorial design using Design Expert-9.0
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Transdermal drug delivery systems are topically administered dosage forms in the patches form that deliver drugs for systemic effects at a predetermined and controlled rate. The purpose of the present study was to formulate and optimize transdermal matrix therapeutic system for Venlafaxine HCl, a low bioavailable drug. HPMC K100, DMSO and propylene glycol were used as polymer, permeation enhancer and plasticizer respectively to formulate the patch. A three-factor, threelevel Box-Behnken design with response surface methodology in Design-Expert Software version-9. was employed to optimize the Transdermal patch. Hydroxypropyl methylcellulose, dimethyl sulphoxide and propylene glycol were varied as independent variables; cumulative Percentage of drug permeated across rat abdominal skin in 12h, flux and Tensile strength were selected as dependent variables. Mathematical equations and response surface plots were used to relate the dependent and independent variables. The statistical validity of polynomials was established, and optimized formulation factors were selected by feasibility and grid search. Validation of the optimization study with five confirmatory runs randomly selected from the Design Expert-9. 0 suggestions indicated high degree of prognostic ability of response surface methodology. Optimized formulation F5 showed the best flux which could meet target flux and about 3. 6 times improvement (P<0.05) in bioavailability, after administration as a transdermal form of Venlafaxine HCl compared to oral administration. Transdermal matrix therapeutic system for Venlafaxine HCl was developed and optimized using Box-Behnken statistical design and could provide an effective Antidepressant dosage form.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mohammed Azizurrahman”

